Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Airway epithelium regeneration refers to the process by which the airway epithelial lining restores itself following injury. The airway epithelium consists of various differentiated cell types, including basal cells (which act as principal stem cells), secretory/club cells, ciliated cells, goblet cells, and ionocytes. Upon injury, quiescent progenitor or basal cells proliferate, migrate, and differentiate to repopulate the epithelial barrier. This process is orchestrated by signals from the underlying mesenchyme such as growth factors (e.g., Wnt, EGF, FGF10), integrin/ECM interactions, and metabolic changes (e.g., a switch from glycolysis to fatty acid oxidation during differentiation). Dysregulation of epithelial regeneration is implicated in diseases like asthma, COPD, infections, and cancer. Because the process involves a variety of cellular and signaling components rather than a single druggable molecule, it is not considered a conventional therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Airway epithelium regeneration.